Connect to other sites within the UBM Medica Network
RFA, SBRT Both Good Options for Unresectable Hepatocellular Carcinoma
Both radiofrequency ablation and stereotactic body radiotherapy are effective in the treatment of inoperable, non-metastatic hepatocellular carcinoma.
Panitumumab Failed in KRAS Wild-Type Biliary Tract Cancer
Adding the EGFR-targeting drug panitumumab to chemotherapy had no effect on survival in a group of patients with wild-type KRAS status advanced biliary tract cancer.
Blood Clots in Abdomen May Be Sign of Cancer
The presence of an abdominal blood clot may be a sign of cancer and may also be associated with poor survival for patients with pancreatic or liver cancers.
PD-1 Inhibitor Yields Responses in Hepatocellular Carcinoma
In this video, Dr. El-Khoueiry discusses results from a phase I/II study that suggest the PD-1 inhibitor nivolumab is safe and effective in advanced hepatocellular carcinoma.
Early Trial Finds Immunotherapy Effective in Liver Cancer
Results from a phase I/II study suggest that the immunotherapy nivolumab is safe and effective in advanced hepatocellular carcinoma (HCC).
Aflatoxin Linked to Risk of Gallbladder Cancer
Aflatoxin, a naturally occurring toxin produced by certain types of molds, has been found to be associated with an increased risk of gallbladder cancer.
Statins Linked With Reduced Liver Cancer in Low-Rate Areas
Current use of statins was associated with about a 50% decreased risk for liver cancer, according to results of a study looking at data from the United Kingdom.
By clicking Accept, you agree to become a member of the UBM Medica Community.